Dopaminergic signaling
Modulated by the ECS through CB1 receptors. The pathway at the center of Solenva's design.
The endocannabinoid system is the body's primary regulatory network. It governs mood, sleep, and muscle tone, and it modulates the dopamine pathway. Solenva™ delivers the Phyto-38 Complex™ to support it.
Three steps, from the system itself to the way Solenva™ engages it.
The endocannabinoid system is the body's primary regulatory network. Its CB1 and CB2 receptors are distributed throughout the central and peripheral nervous system, where they help govern mood, sleep, stress, and muscle tone. It holds these in balance through what is called endocannabinoid tone.
The endocannabinoid system modulates dopaminergic signaling through CB1 receptors in the striatum and basal ganglia. Supporting ECS function supports the dopamine pathway. This connection is the mechanism at the center of Solenva's design.
The Phyto-38 Complex™ engages the same CB1 and CB2 receptors your body already uses, without overstimulating them. It was investigated for dopamine secretion in neuronal cell models, then graduated to early user-experience testing.
When endocannabinoid tone is under-supported, the systems it regulates are the first to show it.
Muscle rigidity that holds through the night and into the morning. Stiffness that makes simple movements cost more than they should.
The ECS helps regulate muscle tone.
Concentration that costs more effort than it should. Emotional weight that sits alongside everything else.
The ECS governs mood and cognition.
Sleep that does not fix the fatigue. Days when steadiness, physical and emotional, feels out of reach.
The ECS influences circadian rhythm, sleep duration, and the return to baseline.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Endocannabinoid tone is built through repetition. Each day reinforces the baseline and moves the system toward homeostasis.
One complex, built to support the endocannabinoid system across the pathways it regulates.
Modulated by the ECS through CB1 receptors. The pathway at the center of Solenva's design.
The balance the ECS maintains. The Phyto-38 Complex™ is built to support it.
Muscle-tone regulation. The highest-burden domain, and the largest average improvement in early testing.
Emotional steadiness and daily concentration, governed by the ECS.
Circadian rhythm and the body's return to a stable baseline.
Phyto-38™ emerged from screening millions of combinations. Four steps, from the pathway to the people.
Start from the endocannabinoid system and its role in dopaminergic signaling.
Evaluate a combinatorial space of over two million cannabinoid combinations.
The combination with the most consistent, reproducible dopaminergic support profile.
Graduate the complex to early user-experience testing across daily-life domains.
Directional, self-reported improvement from early user-experience testing of the Phyto-38 Complex™.
Early user survey of Phyto-38 Complex™. About 2 in 3 of 13 participants reported a noticeable improvement. Self-reported. Individual experiences vary.
Directional, self-reported improvement across the domains measured.
8 of 8 daily-life and 13 of 13 motor measures improved on average; none worsened. Directional, self-reported. Early user testing. Results may vary.
Daily support for your endocannabinoid system and the dopamine pathway it helps regulate.
Start your 90 day protocol →Survey figures reflect a user survey of Phyto-38 Complex™ (N=13): self-reported. Individual experiences vary. Domain figures are directional.
This page is educational and is not medical advice. Solenva™ is a dietary supplement, not a medication. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.